An Audit on Complex hyperplasia reporting at Derriford Hospital

Slides:



Advertisements
Similar presentations
Endometrial polyps Dr Shaun Monagle MBBS 1991.
Advertisements

The Role of Urine cytology in the investigation of Haematuria? B Barrass Audit Meeting 17 th May 2006.
An audit of Endometrial Pathology cases referred to NGOC Dr Paul Cross Consultant Cellular Pathologist Queen Elizabeth Hospital Gateshead.
Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.
Endometrial Cancer May 2007 Dr Anna Winship Guy’s & St. Thomas’ NHS Trust Click Here For First Question Oncology Registrars’ Forum “Best of Five”
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
OPTIONAL LOGO HERE Prevalence of endometrial cancer in symptamatic women with thickened endometrium Dr Maheswari SRINIVASAN MRCOG SpR, Mrs Shagaf BAKOUR.
AUDIT OF COMPLIANCE WITH NHSCSP GUIDELINES REQUIRING MDT REVIEW OF ALL CERVICAL CANCER PATIENTS Dr. M Bhattacharjee Dr. A Mutton Dr. S Nagarajan.
Prostate Cancer Detection in Men with an Initial Diagnosis of Atypical small Acinar Proliferations Dr Charles Chabert The Wollongong Hospital.
A re-audit of Prostate biopsies from January to December 2010 and Dr. M S Siddiqui Consultant Histopathologist University Hospital of North Tees.
Diagnostic Techniques for Endometrial Cancer By:Sara Lotfiyan.
 - an important step in surgical staging for uterine cancer (FIGO 1988)  Stated as 
A significant increase in the incidence of endometrial cancer. This increased incidence of endometrial cancer has been widely interpreted to be a result.
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
A surgical approach to uterine cancer in a single institution August July 2014 M. McCarthy (Medical Student) & M. Hewitt Cork University Maternity.
Endometrial Cancer Screening for Cancer in Women.
Abnormal Uterine Bleeding
E NDOMETRIAL HYPERPLASIA. 44 years old woman, G 2 L 2 History of menorrhagia in last 2years with regular cycle DX : Neg. Lab data ; Hb: 10 coagulation.
Post Menopausal Bleeding
 The term post menopause is applied to women who have not experienced a menstrual bleed for a minimum of 12 months, assuming that they do still have.
Audit of oropharyngeal cancer reporting and frequency of p16 testing at Derriford Hospital. Cost and clinical implications Miss S J Edwards ENT StR Dr.
Post-menopausal bleeding PV Dr Nasira Sabiha Dawood.
Jump to first page First pregnancy after age 30 (RR 1.48). BMI >29 (RR 1.48). Being a college graduate, independent of OB-GYN history (RR 1.36). (Collaborative.
SoftPAP® A Novel Collection Device for Cervical Cytology.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Endometrial Cancer By Jessica Hall. Symptoms Unusual vaginal bleeding or discharge Difficult or painful urination Pain during intercourse Pain in the.
Dr J King, Dr T Bracey Department of cellular pathology, Derriford Hospital May 2014.
Postmenopausal bleeding
April 2014 Dr J King Dr K Syred.  90% mesotheliomas are linked to asbestos exposure  May be eligible for compensation  3 yr survival rate 8%  Subtype.
Adjuvant High-Dose-Rate Brachytherapy Alone for Stage I/II Endometrial Adenocarcinoma using a 4-Gray versus 6-Gray Fractionation Scheme Marie Lynn Racine,
TEMPLATE DESIGN © Background ResultsDiscussion and Conclusion References 1. Glass burn, J., L. Brady,P. Grigsby, Endometrium,
Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.
Endometrial Cancer CPGON Audit. Background Formulating standard management pathways Assessing compliance with existing pathways Understanding areas of.
TEMPLATE DESIGN © Laparoscopic assisted vaginal hysterectomy in a District General Hospital- Audit of clinical practice.
Case 1 Zubair W. Baloch, MD, PhD. Case History 14-year-old girl presented with an enlarging 3.0 cm right thyroid mass. An FNA was performed which was.
CASE PRESENTATION SUPERVISION: DR MOHAMMADIZADE PRESENTATION: DR HEYDARI.
Endometrial polyp, hyperplasia, carcinoma Dr: Salah Ahmed.
Post menopausal bleeding
Synchronous Ovarian and Endometrial Carcinomas; An Unusual Outcome of First Trimester Ultrasound Scanning. Karl McPherson, Rhona Lindsay, Jaimie Thiesen-Nash,
R2 김재민 / Prof. 정재헌 Journal conference 1.
Outcomes Following Urgent Referral for Head & Neck Ultrasound Dr Anna ffrench-Constant Dr Mandy Williams.
Progression model of the two types of endometrial carcinoma
Complex atypical hyperplasia of the endometrium
Malignant disease of the body of the uterus
Malignant disease of the body of the uterus
Postmenopausal bleeding
DEPARTMENT OF CELLULAR PATHOLOGY AND MAXILLOFACIAL SURGERY
CORRELATION OF PHYSICAL EVALUATION AND MRI OF CERVICAL LYMPH NODE WITH HISTOPATHOLOGICAL FINDINGS IN ORAL SQUAMOUS CELL CARCINOMA: AN AMBIDIRECTIONAL STUDY.
Endometrial hyperplasia
Post Menopausal Bleeding
July 2017 Dr Suzannah Yarwood
 [P1]Can you put in the numbers here for specificity and NPV
The Royal Brompton & Harefield Hospitals’ Experience
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
ENDOMETRIAL HYPERPLASIA
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
Malignant disease of the body of the uterus
The postmenopausal bleeding (PMB)
Urologist’s Impact on Extended Needle Core Prostate Biopsy Histopathologic Variables within a Single Institution Kashika G. Goyal B.S.1, Joshua J. Ebel.
Progression model of the two types of endometrial carcinoma
Uterine cancer Uterine mesenchymal neoplasms
M.Boal; J. Batt; P. Wilkerson; D.R. Titcomb
National Data Report 2018 Prof Conor O’Keane
بررسی اثرتشخیصی تکنسیوم 99 و متیلن بلو در بررسی گرفتاری گره لنفاوی sentinel در بیماران مبتلا به سرطان اندومتر کم خطر استاد راهنما: سرکار خانم دکترفریبا.
See-and-treat outpatient hysteroscopy: an analysis of 1109 examinations  Cagri Gulumser, Nitish Narvekar, Mamta Pathak, Elsa Palmer, Sarah Parker, Ertan.
Management of Endometrial Hyperplasia D Hind Showman
AGC&AIS Setareh Akhavan M.D Gynecologist Oncologist
Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report  Giacomo Corrado, M.D., Ph.D., Ermelinda.
Airedale NHS Foundation Trust
SCC MDT Service Evaluation
Presentation transcript:

An Audit on Complex hyperplasia reporting at Derriford Hospital Dr R Khan (SpR) Dr A Oriolowo (Consultant Histopathologist)

Aim To compare the endometrial biopsies reported as complex hyperplasia and the final diagnosis in hysterectomy specimens.

Reporting of small biopsy specimens Tissue Handling: A sieve may be useful to ensure that all the material is retrieved. All the submitted tissue should be processed. Interpretation: Unequivocal distinction between atypical hyperplasia and grade 1 endometrioid carcinoma can be difficult on small biopsies. Outcome: Patients with atypical endometrial hyperplasia may benefit from discussion at the gynaecological oncology MDT and management should be based on clinical, pathological and imaging findings.

Method We looked at reports of endometrial biopsies reported as complex hyperplasia and reviewed their hysterectomy results, over a 5 year period - from 2011 to 2016. We reviewed the slides of endometrial biopsies that were reported as complex hyperplasia without atypia and had hysterectomy diagnosis of endometrioid carcinoma.

Results Total number of endometrial biopsies reported over 5 years (from 2011 to 2016) 10347 Total number of cases of endometrial hyperplasia 438 Total number reported as complex hyperplasia 66 Total number with complex hyperplasia that underwent hysterectomy 65 Total number with complex hyperplasia that did not undergo hysterectomy 1

Biopsy results of cases that underwent hysterectomy Complex hyperplasia without atypia 15 Complex hyperplasia with atypia 50 Total 65

Final Hysterectomy Results Of the 15 reported as complex hyperplasia without atypia underwent hysterectomy for various other reasons. On hysterectomy showed: Complex hyperplasia without atypia 2 Complex hyperplasia with atypia 3 Atrophic/ inactive endometrium 6 Proliferative endometrium Grade 1 Endometrioid carcinoma Total 15

2 cases of grade 1 Endometrioid carcinoma We reviewed the biopsy slides of these two cases and looked if we missed diagnosing atypia. We agreed that there was no atypia

Of the 50 cases reported as complex hyperplasia with atypia On hysterectomy showed: Complex hyperplasia without atypia 2 Complex hyperplasia with atypia 13 Endometrioid carcinoma grade 1 25 Endometrioid carcinoma grade 2 1 Endometrioid carcinoma grade 3 4 Polyp with cystic hyperplasia No hyperplasia/ atrophy/ benign Total 50 Of the above 50 cases, in 8 cases the suspicion of endometrioid ca was raised and 7/8 were grade 1 and 1/8 was grade 3.

Analysis The PPV for endometrial biopsy in this audit is 86%. False positive result of the audit is 8%. False negative result of this audit is 13%.

Discussion case One case (62yr,F): Endometrial curetting showed complex hyperplasia without atypia. Two months later inguinal lymph node sampling showed metastatic endometrioid adenocarcinoma. Died soon after.

We reviewed the biopsy slide of this case We agreed there was no atypia

Conclusion The positive predictive value of endometrial biopsy for carcinoma is affected by the type of biopsy. The diagnosis of cytological atypia is difficult and subjective.

Recommendation 1. Re-audit in an year 2. Look at the different type of biopsy pipelle vs. curettage, and look how it affects the PPV. 3. Consider second opinion in cases of cytological atypia.

References Dataset for histological reporting of endometrial cancer February 2014 by RCPATH